Dermatology Times, June 2022 (Vol. 43. No. 6)

This painful skin disease may lower the odds of live birth and trigger comorbidities.

Advances ranging from combined laser and drug therapies to innovative devices mean patients with acne no longer have to be scared of permanent scarring.

A common complaint in puberty, hormonal acne also affects skin health and quality of life for adults of all genders, driving the need for new solutions.

Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.

Approximately 36% of all physicians will be sued at least once before they are aged 45 years.

In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, tackles the issues of hair loss after pregnancy, the role of pH in hair care, hair strengthening conditioner, and more.

In this month's Legal Eagle, David J. Goldberg, MD, JD, writes about the legal burden of having a chaperone during skin exams.

Investigators explore the effectiveness of new combination therapies to address the multifactorial pathophysiology of acne vulgaris.

Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.

Matthew Zirwas, MD, shares his step-by-step pearls for quelling this pruritic skin condition.

Sol-Gel Technologies and Galderma announce the FDA approval of the 5% benzoyl peroxide, cream for the treatment of inflammatory lesions of rosacea.

In her presentation at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium, Lisa Swanson, MD, discussed the important updates in pediatric dermatology, including early life interventions, food allergies, and more.

Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.

Anne M Chapas, MD, FAAD, discusses what to do when cosmetic procedures go wrong during a presentation at the AAD 2022 annual meeting.

Dermatologists continue to be split on the pros and cons of skin cancer screening, from overdiagnosis to early detection of thin melanomas.

Benjamin Lockshin, MD, FAAD, comments on the significance of recent expansions of therapeutics options for patients with atopic dermatitis and unmet needs in the field.